NASDAQ: NPCE - NeuroPace, Inc.

Lønnsomhet i seks måneder: +53.37%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan NeuroPace, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet NeuroPace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories.

flere detaljer
The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2021-04-22
ISIN US6412881053
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.neuropace.com
Цена ао 10.43
Prisendring per dag: +2.49% (10.43)
Prisendring per uke: -2.82% (11)
Prisendring per måned: -11.58% (12.09)
Prisendring over 3 måneder: -3.08% (11.03)
Prisendring over seks måneder: +53.37% (6.97)
Prisendring per år: -18.89% (13.18)
Prisendring over 3 år: +40.47% (7.61)
Prisendring siden begynnelsen av året: -4.04% (11.14)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 4.08 4
P/BV 40.67 1
P/E 0 0
EV/EBITDA -17.8 0
Total: 3.38

Effektivitet

Navn Betydning Karakter
ROA, % -30.61 0
ROE, % -159.56 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -3.38 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 94.42 9
Lønnsomhet Ebitda, % 73.37 8
Lønnsomhet EPS, % -65.26 0
Total: 3.4
Flere detaljer

Institusjoner Volum Dele, %
KCK Limited 5621111 21.39
Orbimed Advisors LLC. 4003967 15.23
Morgan Stanley 2460716 9.36
Soleus Capital Management, L.P. 2433168 9.26
Nantahala Capital Management, LLC 2347354 8.93
Kent Lake Capital, LLC 670946 2.55
FMR, LLC 468081 1.78
Vanguard Group Inc 413106 1.57
Millennium Management LLC 172403 0.66
Geode Capital Management, LLC 115996 0.44

ETFDele, %Lønnsomhet for året, %Utbytte, %
iShares Micro-Cap ETF 0.02573 17.09 1.54048
Vanguard Russell 2000 Growth ETF 0.01 23.05 0.60264
iShares Russell 2000 Growth ETF 0.00726 38.04 0.6026
ProShares UltraPro Russell2000 0.0022 89.82 1.47873
ProShares Hedge Replication ETF 0.00058 5.92 1.47892
Vanguard Russell 2000 ETF 0 17.16 1.48801
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.0131.851.23



Veileder Stillingstittel Betaling Fødselsår
Dr. Martha J. Morrell Chief Medical Officer 728.68k 1957 (68 år)
Mr. Joel D. Becker CEO, President & Director 762k 1968 (57 år)
Ms. Rebecca L. Kuhn CFO, VP of Finance & Administration, Corporate Secretary and Assistant Secretary 614.91k 1961 (64 år)
Ms. Kelley Nicholas Vice President of Sales N/A
Ms. Leah Akin Acting General Counsel N/A
Mr. Dylan St. John Chief of Operations & Development

Adresse: United States, Mountain View. CA, 455 North Bernardo Avenue - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.neuropace.com